Interleukin 3 (IL 3) Regulates the in Vitro Proliferation of Both Blood Monocytes and Peritoneal Exudate Macrophages: Synergism Between a Macrophage Lineage-specific Colony-stimulating Factor (CSF-1) and IL 3
Overview
Affiliations
The effect of interleukin 3 (IL 3) on regulation of macrophage proliferation was examined. Although IL 3 alone stimulates the colony formation in bone marrow cells, it fails to stimulate the colony formation by both peritoneal exudate macrophages (PEM) and blood monocytes. However, IL 3 greatly enhances the proliferative capacity of both PEM and monocytes in responding to suboptimal concentrations of CSF-1. At supraoptimal concentrations of CSF-1, IL 3 did not increase the number of colonies, but greatly increased colony size. Kinetic studies showed that IL 3 enhances CSF-1-induced macrophage proliferation by shortening the cell doubling time. Monocytes were more sensitive to the action of IL 3 and possessed higher proliferative potential than PEM. Binding studies with radioactive labeled CSF-1 (125I-CSF-1) showed that IL 3 treatment induced an increased expression of CSF-1 receptor activity by PEM which appears to be a result of increased number of available receptor sites. The effect of IL 3 on the expression of receptor activity is both dose- and time-dependent. IL 3 also augments the rate of receptor-mediated CSF-1 endocytosis by PEM which appears to be a direct result of increased expression of CSF-1 binding sites. These results demonstrate that, in addition to stimulating the growth and differentiation of several blood cell lineages by hemopoietic stem cells, IL 3 also possesses the ability to modulate CSF-1 receptors, thereby affecting proliferation of more mature blood monocytes and tissue-derived macrophages.
Integrated analysis of immunometabolic interactions in Down syndrome.
Gillenwater L, Galbraith M, Rachubinski A, Eduthan N, Sullivan K, Espinosa J Sci Adv. 2024; 10(50):eadq3073.
PMID: 39671500 PMC: 11641111. DOI: 10.1126/sciadv.adq3073.
Reconditioned monocytes are immunomodulatory and regulate inflammatory environment in sepsis.
Jain K, Mohan K, Roy G, Sinha P, Jayaraman V, Kiran Sci Rep. 2023; 13(1):14977.
PMID: 37696985 PMC: 10495550. DOI: 10.1038/s41598-023-42237-4.
Hematopoietic growth factor receptors.
Shieh J, Moore M Cytotechnology. 2012; 2(4):269-86.
PMID: 22358869 DOI: 10.1007/BF00364993.
Muller J, Yoshida T Inflamm Res. 1996; 45(12):593-9.
PMID: 8988404 DOI: 10.1007/BF02312041.
Muller I, Kropf P, Louis J, Milon G Infect Immun. 1994; 62(6):2575-81.
PMID: 8188380 PMC: 186547. DOI: 10.1128/iai.62.6.2575-2581.1994.